BL is an uncommon form of highly aggressive B-cell non-Hodgkin lymphoma, in whose pathogenesis several other oncogenes, such as TCF3, collaborate with MYC [91]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.